Healthcare
NASDAQ companies operating within the Healthcare sector, ranked by market capitalization.
| DMRA | NASDAQ | Damora Therapeutics, Inc. | $28.82 | -1.20% | 565K | $1.77B |
| ANIP | NASDAQ | ANI Pharmaceuticals, Inc. | $77.65 | -1.12% | 158K | $1.77B |
| WGS | NASDAQ | GeneDx Holdings Corp. | $59.10 | -6.75% | 430K | $1.75B |
| WGSWW | NASDAQ | GeneDx Holdings Corp. | $0.00 | -2.70% | 1.7M | $1.75B |
| VRDN | NASDAQ | Viridian Therapeutics, Inc. | $19.27 | +0.05% | 1.5M | $1.73B |
| GENB | NASDAQ | Generate Biomedicines, Inc. | $13.40 | -3.11% | 321K | $1.72B |
| AAPG | NASDAQ | Ascentage Pharma Group International | $19.24 | -1.94% | 5K | $1.7B |
| ZYME | NASDAQ | Zymeworks Inc. | $22.86 | -1.12% | 272K | $1.68B |
| SRPT | NASDAQ | Sarepta Therapeutics, Inc. | $15.68 | -1.26% | 2.1M | $1.66B |
| ABCL | NASDAQ | AbCellera Biologics Inc. | $5.31 | -6.35% | 6.3M | $1.62B |
| INVA | NASDAQ | Innoviva, Inc. | $21.71 | -2.25% | 550K | $1.58B |
| MLTX | NASDAQ | MoonLake Immunotherapeutics | $19.02 | -1.76% | 651K | $1.57B |
| INNV | NASDAQ | Innovage Holding Corp. | $11.50 | -3.12% | 173K | $1.57B |
| HCSG | NASDAQ | Healthcare Services Group, Inc. | $25.31 | +1.30% | 930K | $1.56B |
| RXRX | NASDAQ | Recursion Pharmaceuticals, Inc. | $3.56 | -5.32% | 16.5M | $1.55B |
| IART | NASDAQ | Integra LifeSciences Holdings Corporation | $19.79 | +6.63% | 901K | $1.54B |
| MAZE | NASDAQ | Maze Therapeutics, Inc. | $27.68 | -0.04% | 166K | $1.53B |
| CMPS | NASDAQ | COMPASS Pathways plc | $11.26 | -3.84% | 3.6M | $1.52B |
| SEPN | NASDAQ | Septerna Inc | $33.10 | -1.11% | 242K | $1.49B |
| BCAX | NASDAQ | Bicara Therapeutics Inc. Common Stock | $27.02 | -2.56% | 480K | $1.48B |
| AVBP | NASDAQ | ArriVent BioPharma, Inc. | $33.19 | +1.31% | 475K | $1.48B |
| VIR | NASDAQ | Vir Biotechnology, Inc. | $8.69 | -6.96% | 2.2M | $1.47B |
| BLFS | NASDAQ | BioLife Solutions, Inc. | $29.98 | -2.57% | 2.6M | $1.46B |
| AHCO | NASDAQ | AdaptHealth Corp. | $10.76 | +2.77% | 822K | $1.46B |
| XNCR | NASDAQ | Xencor, Inc. | $19.52 | +0.03% | 633K | $1.44B |
| XERS | NASDAQ | Xeris Biopharma Holdings, Inc. | $8.28 | +1.47% | 1.2M | $1.44B |
| HROW | NASDAQ | Harrow Health, Inc. | $38.45 | -8.19% | 889K | $1.43B |
| PNTG | NASDAQ | The Pennant Group, Inc. | $40.50 | +0.10% | 176K | $1.43B |
| NKTR | NASDAQ | Nektar Therapeutics | $70.73 | +1.97% | 836K | $1.38B |
| PAHC | NASDAQ | Phibro Animal Health Corporation | $34.04 | +0.68% | 137K | $1.38B |
| ABSI | NASDAQ | Absci Corporation | $7.56 | -6.32% | 2.6M | $1.28B |
| MNKD | NASDAQ | MannKind Corporation | $4.03 | -0.25% | 9.4M | $1.28B |
| AKTS | NASDAQ | Aktis Oncology, Inc. | $24.81 | +0.73% | 194K | $1.28B |
| ATEC | NASDAQ | Alphatec Holdings, Inc. | $8.26 | +0.61% | 1.5M | $1.27B |
| AZTA | NASDAQ | Azenta, Inc. | $26.29 | -1.83% | 695K | $1.26B |
| ORIC | NASDAQ | ORIC Pharmaceuticals, Inc. | $12.10 | +11.11% | 3.6M | $1.25B |
| ARDX | NASDAQ | Ardelyx, Inc. | $5.20 | +1.46% | 1.7M | $1.24B |
| TRAX | NASDAQ | First Tracks Biotherapeutics Inc | $36.24 | +11.85% | 495K | $1.24B |
| AVLN | NASDAQ | Avalyn Pharma Inc. Common Stock | $28.36 | +0.29% | 140K | $1.24B |
| KMTS | NASDAQ | Kestra Medical Technologies, Ltd. | $20.89 | -6.07% | 176K | $1.23B |
| PSNL | NASDAQ | Personalis, Inc. | $12.22 | -2.00% | 2.9M | $1.23B |
| NVAX | NASDAQ | Novavax, Inc. | $7.46 | -4.66% | 3.2M | $1.23B |
| OMDA | NASDAQ | Omada Health | $20.53 | -3.16% | 1.2M | $1.22B |
| IMTX | NASDAQ | Immatics N.V. | $9.68 | -2.81% | 290K | $1.22B |
| IRMD | NASDAQ | IRadimed Corporation | $94.49 | +0.67% | 80K | $1.21B |
| NTLA | NASDAQ | Intellia Therapeutics, Inc. | $10.73 | -3.33% | 3.5M | $1.2B |
| INBX | NASDAQ | Inhibrx Biosciences Inc. | $81.55 | -4.06% | 165K | $1.2B |
| TNDM | NASDAQ | Tandem Diabetes Care, Inc. | $17.12 | +1.30% | 1.1M | $1.17B |
| CERT | NASDAQ | Certara, Inc. | $7.51 | +5.63% | 5.6M | $1.17B |
| ETON | NASDAQ | Eton Pharmaceuticals, Inc. | $37.19 | -3.40% | 386K | $1.17B |